Monte Carlo investigation of the shielding performance of B(2)O(3)-based glasses against ionizing radiation

利用蒙特卡罗方法研究B₂O₃基玻璃对电离辐射的屏蔽性能

阅读:1

Abstract

This study investigated the shielding properties of five glass samples (same molecular composition, varying component percentages) against nuclear radiation using Geant4 Monte Carlo. Calculations determined the linear attenuation coefficient, MFP, TVL, and HVL for the samples against [Formula: see text](60 keV), [Formula: see text](662 keV), and [Formula: see text] (1.2 MeV) sources. Mass attenuation coefficients were calculated and compared with XCOM data. Photon intensity reduction was analyzed. Given the [Formula: see text] base and boron's neutron absorption, neutron shielding was expected. The samples were tested against [Formula: see text]-Be and [Formula: see text] mixed sources, calculating reduced neutron/photon flux and transmitted radiation spectra. Proton beam shielding was investigated, determining the maximum proton energy stopped by each sample. Using a MIRD phantom and the [Formula: see text]source, dose reduction in the body and organs due to the shields was calculated. Results show higher density improves shielding; sample 5 (densest) performed best. For photons, sample 5's shielding was ~ 3.2 greater than sample 1 at 60 keV, and ~ 1.2 greater at 1.2 MeV. Lower energies showed better shielding, with [Formula: see text]performing better overall. 1 cm thick samples against protons showed denser samples had higher shielding; sample 1 stopped 53 MeV protons, increasing by 1 MeV per sample to sample 5.2 cm thick samples between the [Formula: see text]source and MIRD phantom reduced whole-body dose by 28% (sample 1) and 40% (sample 5). Simulation is a cost-effective way to assess shielding performance, revealing strengths and weaknesses against various radiation types and energies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。